Palisade Bio, Inc. (PALI) stock
PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.12−0.02 (-1.75%)
Close on Nov 13, 2026Market cap $195.18MP/E –Yield –
Palisade Bio ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Palisade Bio's ebitda for the twelve months ending Sep 30, 2023 was -$13.76M. For fiscal 2022 it was -$15.72M. The highest annual figure on record is -$8.07M in fiscal 2018.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -$15.72M | – |
| FY2021 | Dec 31, 2021 | -$41.85M | – |
| FY2020 | Dec 31, 2020 | -$9.29M | – |
| FY2019 | Dec 31, 2019 | -$8.49M | – |
| FY2018 | Dec 31, 2018 | -$8.07M | – |
| FY2017 | Dec 31, 2017 | -$13.02M | – |
| FY2016 | Dec 31, 2016 | -$20.30M | – |
| FY2015 | Dec 31, 2015 | -$18.81M | – |
| FY2014 | Dec 31, 2014 | -$17.09M | – |
| FY2013 | Dec 31, 2013 | -$12.28M | – |
| FY2012 | Dec 31, 2012 | -$9.95M | – |
| FY2011 | Dec 31, 2011 | -$12.80M | – |
| FY2010 | Dec 31, 2010 | -$15.05M | – |
| FY2009 | Dec 31, 2009 | -$10.38M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | -$3.78M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.61M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.53M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.85M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.41M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.57M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.89M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.03M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.02M | – |
| Q2 FY2021 | Jun 30, 2021 | -$32.86M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.95M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.24M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.82M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.87M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.96M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.10M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.09M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.88M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.42M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.78M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.04M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.98M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.28M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.21M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.53M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.15M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.12M | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.59M | – |
See a number that looks wrong?